Skip to main content
Caplight Logo









Tempest Therapeutics

Tempest Therapeutics

Public
Brisbane, CaliforniaBiotechwww.tempesttx.com

Tempest Therapeutics is now publicly traded

The data on this page reflects Tempest Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Apr 3, 2026

Total Funding Raised

$2M

Company Overview

Tempest Therapeutics (NAS: TPST) is a biotechnology company focused on developing small molecule therapeutics that aim to directly eliminate tumor cells and enhance tumor-specific immune responses in cancer treatment.

Sector

Biotech

AI Layer

Non-AI

Keywords

oral small-molecule oncology therapeuticsoral PPARα antagonist for cancerfirst-line combination therapy for hepatocellular carcinomadual-mechanism cancer therapysolid tumor therapeutic developmentdual EP2 and EP4 prostaglandin receptor antagonisttumor microenvironment modulation therapyclinical-stage oncology companyoral TREX1 enzyme inhibitorcGAS/STING immune pathway activationoncology drug licensing and partnership model

Tempest Therapeutics Comparables

Compare Tempest Therapeutics with similar companies based on industry and business-model similarity.

Tempest Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ethonova
73%
FGH BioTech, Inc.
55%
Euclises Pharmaceuticals
49%
View all Comparables

Tempest Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementApr 3, 2026
View all Funding Rounds

Tempest Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tempest Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersBrisbane, California
Year Founded2011
Last FundingApr 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?